Company: VERA
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0000950170-25-064733
Chunk: 12

Company: Vera Therapeutics, Inc.
Filing Date: 2025-05-07
Form: 10-Q
Item: Part II, Item 5
Chunk 12
---
Trading ArrangementsDuring the quarter ended March 31, 2025, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities set forth in the table below. 

       Type of Trading Arrangement

       Name
       Position
       Action
       Adoption/ TerminationDate
       Rule 10b5-1*
       Non-Rule 10b5-1**
       Total Shares of Class A Common Stock to be Sold***
       Total Shares of Class A Common Stock to be Purchased
       Expiration Date

       William Turner
       Chief Development Officer
       Adoption
       February 20, 2025
       X
        
       Up to 40,000
       N/A
       December 18, 2025

       * Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

       ** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act. 

       *** Represents the maximum number of shares that may be sold pursuant to the 10b5-1 trading arrangement. The number of shares to be sold was dependent on the satisfaction of certain conditions as set forth in the written plan.